Pure Global Joins International Trade Administration’s BSP Directory for China

The European Commission updated its consolidated list of links to Notified Body standard-fee schedules on 13 July 2026. The list helps medical device and IVD manufacturers access published certification fee information for budgeting and Notified Body selection.

MDCG 2026-5 confirms that UDI-DIs must remain linked to the manufacturer in private-label and distributor-brand arrangements. Manufacturers retain legal responsibility for UDI assignment, maintenance, and EUDAMED registration, even when practical activities are delegated.

The World Health Organization recognized Brazil’s ANVISA as a Transitional WHO Listed Authority for Medical Devices (tWLAs-MD) on 1 July 2026, acknowledging its regulatory oversight of medical devices and IVDs. The designation supports WHO’s transition to the WHO Listed Authorities framework, promoting international regulatory reliance and confidence in ANVISA’s decisions.